Your search
Results 28 resources
-
These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of viral hepatitis in the pre- and post-transplant period. The current guidelines reflect the declining need for hepatitis B immunoglobulin following liver transplant, now replaced with nucleos(t)ide analogues that effectively suppress viral replication for the long term with minimal risk for drug resistance. It describes the...
-
PurposeTo provide an updated joint ASCO/Infectious Diseases Society of America (IDSA) guideline on antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its treatment.MethodsASCO and IDSA convened an update Expert Panel and conducted a systematic review of relevant studies from May 2011 to November 2016. The guideline recommendations were based on the review of evidence by the Expert Panel.ResultsSix new or updated meta-analyses and six new primary...
-
An abstract is unavailable.
-
<h2>Summary</h2><p>Viral hepatitis affects millions of people worldwide, and host immunity is the key determinant of patient outcome. Viral hepatitis can be life threatening in patients with haematological malignancy, including haemopoietic stem cell transplant recipients, because of the virus itself, or through a need to decrease the dose of chemotherapy. A past or currently infected haemopoietic stem cell donor could also transmit viral hepatitis. The burden of viral hepatitis in patients...
-
Background Indefinite, long-term administration of hepatitis B immunoglobulins (HBIg), together with a third generation nucleos(t)ide analog (NA), is the currently recommended prophylactic strategy to prevent viral recurrence after liver transplantation (LT) for Hepatitis Delta virus (HDV)/Hepatitis B virus (HBV)-related disease. Methods We retrospectively analyzed the safety and long-term clinical and virological outcomes of a consecutive cohort of 16 patients (10 males, median age 64.5,...
-
Background The use of vaccination to prevent infection has a long history, starting in the 1700s with Jenner. New innovations have led to improvements in the safety and efficacy of vaccines, from live attenuated viruses to subunit vaccines, to RNA-based vaccination for SARS-CoV-2. Despite this progress, however, solid organ transplant (SOT) recipients on immunosuppression demonstrate an impaired vaccine response compared with healthy controls. This issue is important given the increased...
Filter by our tag
GUIDELINES
- AASLD Guidelines (2)
- AST Guidelines 2019 (1)
- ECIL Guidelines (1)
- IDSA Guidelines (2)
TEXTBOOKS
ORGANISMS
-
VIRUSES
- Hepatitis B
-
COVID-19
(1)
- Vaccination (1)
- Hepatitis A (1)
- Hepatitis C (4)
- Hepatitis D (5)
- Hepatitis E (1)
- HIV (1)
- Influenza (1)
- Mpox (1)
- Respiratory Viruses (1)
- VZV (2)
DRUGS AND THERAPIES
- Antifungals (1)
PREVENTION
- Vaccination (5)
HEME-ONC AND CELLULAR THERAPIES
- Biologics (1)
- BMT Basics (1)
- BMT Guidelines (1)
- Heme-onc prophylaxis (1)
- Neutropenia (1)
- TK inhibitors (1)
ARTICLE OF THE MONTH
- 2023 (1)
ATC 2024 Top Papers in TID
- VIRUSES (1)